Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
ALX Oncology Holdings Inc. (ALXO) had Return on Equity of -118.69% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-134.85M |
|
-- |
|
-- |
|
$142.47M |
|
$-142.47M |
|
$7.62M |
|
$-134.85M |
|
$-134.85M |
|
$-134.85M |
|
$-134.85M |
|
$-134.85M |
|
$-134.85M |
|
$-142.47M |
|
$-145.99M |
|
52.17M |
|
52.17M |
|
$-2.58 |
|
$-2.58 |
|
| Balance Sheet Financials | |
$134.35M |
|
$2.90M |
|
$13.42M |
|
$147.78M |
|
$18.50M |
|
$9.47M |
|
$15.66M |
|
$34.16M |
|
$113.62M |
|
$113.62M |
|
$113.62M |
|
53.05M |
|
| Cash Flow Statement Financials | |
$-121.91M |
|
$86.26M |
|
$30.82M |
|
$22.47M |
|
$17.63M |
|
$-4.84M |
|
$27.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.26 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-122.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-118.69% |
-118.69% |
|
-91.25% |
|
-109.56% |
|
$2.14 |
|
$-2.35 |
|
$-2.34 |
|